A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis

Completed · Phase 2

Conditions studied: Arthritis, Psoriatic, Psoriasis

In brief

This is a placebo controlled study evaluating the role of fludarabine (a nucleoside analog targeting both resting and proliferating lymphocytes) in the treatment of moderate to severe psoriotic arthritis. Patients should have failed at least one disease modifying antirheumatic drug.

Key facts

Study ID
NCT00001422
Run by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
People needed
20
Starts
1995-06-01
Expected to finish
2000-04-01
Last updated by the study team
2008-03-04

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.